Accreditation Statements

Developed through a partnership between Medscape and the Endocrine Society.

As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's Special Programs Committee (SPC). The commercial supporter(s) of this activity have no influence over the planning of this CME activity.

For Physicians

• 

• The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved accreditation with commendation. 

  The Endocrine Society designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

  STATEMENT OF INDEPENDENCE 

  As a provider of CME accredited by the Accreditation Council for Continuing Medical 

  Education, the Endocrine Society has a policy of ensuring that the content and 

  quality of this educational activity are balanced, independent, objective, and 

  scientifically rigorous. The scientific content of this activity was developed under the 

  supervision of the Endocrine Society’s guideline task force. 

  DISCLOSURE POLICY 

  The faculty, committee members, and staff who are in position to control the 

  content of this activity are required to disclose to the Endocrine Society and to 

  learners any relevant financial relationship(s) of the individual or spouse/partner 

  that have occurred within the last 24 months with any commercial interest(s) whose 

  products or services are related to the content. Financial relationships are defined 

  by remuneration in any amount from the commercial interest(s) in the form of 

  grants; research support; consulting fees; salary; ownership interest (e.g., stocks, 

  stock options, or ownership interest excluding diversified mutual funds); honoraria 

  or other payments for participation in speakers; bureaus, advisory boards, or 

  boards of directors; or other financial benefits. The intent of this disclosure is not to 

  prevent planners with relevant financial relationships from planning or delivery of 

  content, but rather to provide learners with information that allows them to make 

  their own judgments of whether these financial relationships may have influenced 

  the educational activity with regard to exposition or conclusion. 

  The Endocrine Society has reviewed all disclosures and resolved or managed all 

  identified conflicts of interest, as applicable. 

  DISCLAIMERS 

  USE OF PROFESSIONAL JUDGMENT: The educational content in this activity relates 

  to basic principles of diagnosis and therapy and does not substitute for individual 

  patient assessment based on the health care provider’s examination of the patient 

  and consideration of laboratory data and other factors unique to the patient. 

  Standards in medicine change as new data become available. 

  DRUGS AND DOSAGES: When prescribing medications, the physician is advised to 

  check the product information sheet accompanying each drug to verify conditions 

  of use and to identify any changes in drug dosage schedule or contraindications. 

  POLICY ON UNLABELED/OFF-LABEL USE: The Endocrine Society has determined 

  that disclosure of unlabeled/off-label or investigational use of commercial 

  product(s) is informative for audiences and therefore requires this information to 

  be disclosed to the learners at the beginning of the presentation. Uses of specific 

  therapeutic agents, devices, and other products discussed in this educational 

  activity may not be the same as those indicated in product labeling approved by the 

  Food and Drug Administration (FDA). The Endocrine Society requires that any 

  discussions of such “off-label” use be based on scientific research that conforms to 

  generally accepted standards of experimental design, data collection, and data 

  analysis. Before recommending or prescribing any therapeutic agent or device, 

  learners should review the complete prescribing information, including indications, 

  contraindications, warnings, precautions, and adverse events. 

  PRIVACY AND CONFIDENTIALITY STATEMENT: The Endocrine Society will record 

  learner’s personal information as provided on CME evaluations to allow for 

  issuance and tracking of CME certificates. The Endocrine Society may also track 

  aggregate responses to questions in activities and evaluations and use these data 

  to inform the ongoing evaluation and improvement of its CME program. No 

  individual performance data or any other personal information collected from 

  evaluations will be shared with third parties.

  Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]